Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Novatus Energy extends service agreements to 20 years with Vestas for 1,043 MW fleet in the U.S.

News release from Vestas – American Wind Technology and Novatus EnergyPortland, 29 March 2019  Novatus Energy has signed long-term comprehensive service agreement extensions with Vestas across seven wind projects totalling 1,043 MW in the U.S. The agreements extend the original Vestas service contracts at the projects from their original ten-year terms, to 20-year terms from their respective project commercial operation dates.   “We are excited to extend our working relationship with Vestas on our U.S. wind portfolio.  Vestas has been a key part of our focus on maintaining high

Moberg Pharma completes the divestment of the OTC-business for USD 155 million

STOCKHOLM, March 29th, 2019. Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has today completed the divestment of its OTC-business (over-the-counter) to RoundTable Healthcare Partners and Signet Healthcare Partners (the “Purchaser”) for USD 155 million. After the divestment, Moberg Pharma’s remaining business consists of the development and commercialisation of new pharmaceutical products. The transaction enables Moberg Pharma to further focus resources on the pipeline program (MOB-015 in particular) and distribute significant value to its shareholders. The Company intends to use

Vestas receives 220 MW order in USA with 25-year service agreement

News release from Vestas-American Wind TechnologyPortland, 29 March 2019 Vestas has received an order for 220 MW of V120-2.2 MW turbines for a wind project in the USA. Underlining Vestas’ ability to deliver optimised project performance and reliability, the order includes supply and commissioning of the turbines as well as a 25-year Active Output Management 5000 (AOM 5000) service agreement. “We are proud to expand our 2 MW platform footprint and to have been chosen to perform long-term service at the site”, said Chris Brown, President of Vestas’ sales and service division in the

Ericsson Annual Report on Form 20-F filed with the SEC

On March 29, 2019, Ericsson (NASDAQ:ERIC) filed its Annual Report on Form 20-F for the year ended December 31, 2018 with the U.S. Securities and Exchange Commission (SEC). The Annual Report is available on Ericsson's website at https://www.ericsson.com/en/investors. Shareholders may request a hard copy of the Annual Report by contacting the company. NOTES TO EDITORS: FOLLOW US: Subscribe to Ericsson press releases here . www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericsson

BIMobject acquires Polantis and strengthens its market-leading position

BIMobject has entered into an agreement to acquire one of the largest European BIM solutions companies, Polantis. The closing is estimated today, and the acquisition is expected to have a small positive effect on net revenues. The acquisition of Polantis is an important strategic step as it further establishes BIMobject as the global market leader. Polantis is a well-known and strong brand in France foremost but also across the world. Polantis has 420,000 registered users, 14,700 objects and 150 manufacturers on the platform. Polantis management forecast €700,000 in sales 2019.

Results of Placing

29 March 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, SOUTH AFRICA, AUSTRALIA, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. Results of Placing AstraZeneca PLC (the "Company" or "AstraZeneca") is pleased to announce the

Ljusgårda AB Continues Expansion with Investment in Heliospectra’s Innovative LED Lighting Solutions

(GOTHENBURG, Sweden/SAN FRANCISCO, CA, March 29, 2019 – Heliospectra AB (publ) (OTCQB: HLSPY, FIRST NORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a second order from Ljusgårda AB. The company is expanding its business in Tibro, Sweden, with additional orders of Heliospectra’s fully adjustable ELIXIA LED lighting solutions. The company is currently using the ELIXIA solution in combination with Heliospectra’s light control system helioCORE™. The order value is SEK 5.7 million (USD $ 611,450).Expanding a

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sverige, 18:00 CET, 29 March 2019 – During the month of March, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased due to directed issue and repurchase of 505,000 series C shares, which were resolved upon by the board of directors on 1 March 2019 pursuant to the authorizations granted by the annual general meeting on 22 May 2018. As of 29 March 2019, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 52,300,917 shares, of which 51,795,917 are ordinary shares with one vote per share and 505,000 are series C shares with one-tenth of a vote per

SpareBank 1 Nord-Norge (NONG): Extraordinary dividend from SpareBank 1 Gruppen AS paid

Reference is made to the establishment of Fremtind Forsikring AS on 01/01/2018 as the result of the merger of SpareBank 1 Skadeforsikring AS and DNB Forsikring AS. The notice to the stock exchange issued on 21/12/2018 stated what the financial impact of the merger would be for SpareBank 1 Gruppen AS and its owners in SpareBank 1 Gruppen. The transaction agreement assumed a conversion ratio of 80% for SpareBank 1 Gruppen AS and 20% for DNB ASA. This conversion ratio was based on a negotiated market value for the two non-life insurance companies, inclusive of the value of the personal risk

BlackRock's shareholding in UPM has gone below the threshold of 5 per cent

UPM-Kymmene Corporation     Stock Exchange Release (Flagging Release) 29 March 2019 at 18:30 EET BlackRock's shareholding in UPM has gone below the threshold of 5 per cent UPM-Kymmene Corporation has on 29 March 2019 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect holding of UPM shares and voting rights has gone below the threshold of 5 per cent on 28 March 2019. According to the announcement, BlackRock, Inc.'s indirect shareholding in UPM has decreased to 26,494,178 shares, corresponding to 4.96 per

Nel ASA: Approval and publication of Prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Nel ASA: Approval and publication of Prospectus (Oslo, 29 March 2019) Reference is made to the stock exchange announcement by Nel ASA ("Nel" or the "Company") on 31 January 2019, regarding key information relating to a subsequent offering of up to 12,500,000 new shares (the "Subsequent Offering") in the Company following the completion of a private

Change in number of shares and votes in Ascelia Pharma AB (publ)

During March, the registered number of shares and votes in Ascelia Pharma AB (publ) has increased due to the new issue that was executed in connection with the listing of the company’s shares on Nasdaq Stockholm. As of 29 March 2019, the registered number of shares and votes in Ascelia Pharma AB (publ) amounts to 22,606,891.For more information, please contactMagnus Corfitzen, CEOEmail: moc@ascelia.comTel: +46 735 179 110 Mikael Widell, IR & Communications ManagerEmail: mw@ascelia.comTel: +46 703 11 99 60This information is such information as Ascelia Pharma AB (publ) is

Major League Baseball Players Alumni Association and Youth Futures International to Host Golf Tournament in Las Vegas

Event to feature Tommy Davis, Rollie Fingers and Joe RudiColorado Springs, Colo. – The Major League Baseball Players Alumni Association and Youth Futures International  will host a celebrity golf tournament featuring Hall of Famers, former MLB All-Stars, World Series champions and other alumni. The event will take place on Monday, April 1st, 2019 with proceeds benefitting Youth Futures International, a non-profit maximizing young leaders’ potential to impact their world through public health, education and sports initiatives. Alumni players attending* the

New number of shares and votes in Lime Technologies AB (publ)

During March a total of 783,481 new shares in Lime Technologies AB (publ) were issued as a result of the exercise of warrants in the 2014/2019 and 2015/2019 series (both of which were issued as part of employee incentive programs). Following the exercise, there are no further warrants outstanding. As of March 29, 2019, the last trading day of the month, the total number of shares and votes in Lime Technologies amounts to 13,283,481. Each share carries one vote. For more information, contact: Lime Technologies AB (publ) Magnus Hansson, CFO / +46 708-55 55 40 / magnus.hansson@lime.

Ossur Hf : Össur's total share capital

Announcement no. 22/201929 March 2019 Össur's total share capital According to Article 84 of the Icelandic Act on Securities Transactions no. 108/2007, an issuer shall publish information on its total share capital on the last trading day of the month when the share capital has been decreased. Össur's total share capital is ISK 425,377,804 nominal value divided into the same number of shares with a nominal value of ISK 1 each following the share capital decrease. For further information, see the Company's announcement no. 21/2019 published earlier today. Further information

Ossur Hf : Registration of capital reduction of 5,430,259 shares completed

Announcement no. 21/201929 March 2019 Registration of capital reduction of 5,430,259 shares completed Reference is made to the Company's announcement no. 16/2019 published on 7 March 2019. The capital reduction of ISK 5,430,259 nominal value was registered with the Icelandic Register of Enterprises today. 5,430,259 own shares with a nominal value of ISK 1 each were cancelled. The share capital of Össur is now ISK 425,377,804 nominal value divided into the same number of shares with a nominal value of ISK 1 each. The Company currently holds 1,110,364 own shares. The shares

Fennia has withdrawn from Hippos2020-project - Lehto committed to continue preparation of the project

Lehto Group PlcInsider information29 March 2019 at 5.45 p.m. (EET)Fennia Asset Management Ltd (”Fennia”) has informed 29 March 2019 that Fennia will not continue in Hippos2020-project. Lehto is still committed to continue the preparation of Hippos2020-project and will evaluate the changed status with the city of Jyväskylä during the next weeks. According to the current  information which is available, Lehto cannot evaluate the impact of Fennia’s withdrawal for schedule of the project neither the timing of costs and incomes.

Positive reception of InCoax’s In:xtnd™ solution at Fiberdays19

InCoax presented In:xtnd™ at the Fiberdays19 fair in Wiesbaden 27-28 March.InCoax presented  and demonstrated In:xtnd and received a lot of interest and requests for quotes for evaluation kits which is the first step in a customer journey. Germany is one of InCoax’s targeted markets with a lot of existing coaxial infrastructure in buildings and fibre now being rolled out in the streets. “We see a large potential to help solve the challenge in Germany connecting the fiber in the street to the consumers in an

Share buy-back by Zalaris ASA

On 29 March 2019, Zalaris ASA purchased 3.758 own shares on the Oslo Stock Exchange at an average price of NOK 24,0013. Following the purchase Zalaris ASA holds 191.314 own shares, representing ~0,95% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

SpareBank 1 SR-Bank ASA (SRBANK); Extraordinary dividend from SpareBank 1 Gruppen AS paid

Reference is made to the establishment of Fremtind Forsikring AS on 01/01/2018 as the result of the merger of SpareBank 1 Skadeforsikring AS and DNB Forsikring AS. The notice to the stock exchange issued on 21/12/2018 stated what the financial impact of the merger would be for SpareBank 1 Gruppen AS and its owners in SpareBank 1 Gruppen. The transaction agreement assumed a conversion ratio of 80% for SpareBank 1 Gruppen AS and 20% for DNB ASA. This conversion ratio was based on a negotiated market value for the two non-life insurance companies, inclusive of the value of the personal risk

The world ́s best photography is on it ́s way to Tallinn

Initially opened in Stockholm in 2010, the Fotografiska family is now growing. We proudly announce our new opening in Tallinn this June 2019. Tallinn will be the first Fotografiska to open outside Sweden, followed by New York and London. In these prime locations, Fotografiska aims to redefine the traditional museum experience by creating urban meeting places where global citizens are invited to dwell, get inspired, question conventions and grow as individuals.Dedicated to offering unforgettable experiences with world-class photography to the masses, Fotografiska is now embarking on a

District Court of Delaware rules that Actavis does not infringes with their Suboxone® and Subutex® generics

Uppsala, Sweden - March 29, 2019 – Orexo AB (publ.), the fully integrated specialty pharmaceutical company, with strong long-term patent protection (no. 8,940,330) for its key product, Zubsolv® in the US, until September 2032, announces that the US District Court for the District of Delaware has declared that Actavis does not infringes Zubsolv´s short-term US patent no. 8,454,996 (“996”), expiring in September 2019, with their generic versions of Suboxone® and Subutex® in the patent infringement litigation against Actavis Elizabeth LLC, Actavis Pharma, Inc., and their parent company Teva (

Artificial Solutions’ CEO Lawrence Flynn to Speak at ABG Sundal Collier Stockholm

Stockholm, Sweden, 29 March 2019 – Artificial Solutions ® (FNSE:ASAI), the leading specialist in enterprise-strength conversational AI, announced today that Lawrence Flynn, CEO of Artificial Solutions, will present at ABG Sundal Collier’s Artificial Intelligence in Practice Seminar in Stockholm on the 3rd April at 11:30 am Central European Time. Lawrence will discuss how conversational interfaces are changing the way people interact with technology and why Artificial Solutions’ award-winning, conversational AI development platform, Teneo®, is the

Vestas develops cost-competitive solution to secure 47 MW subsidy-free project in the UK

News release from Vestas Northern and Central EuropeHamburg, 29 March 2019 Douglas West Wind Farm Ltd, owned by Greencoat UK Wind plc, has placed an order with Vestas for a 47 MW project to be located in South Lanarkshire, Scotland. Underlining onshore wind’s status as the most cost-competitive energy source, the project will be UK’s first standalone merchant wind park progressing to be built without any direct financial support. The wind park features the first 136m Vestas rotors in the UK and by utilising the newest and most advanced technology, the customer will realise the

There are no items matching the current filter
There are no more items matching the current filter
Back to top